EGFR-tyrosine kinase inhibitors - Globe Thesis

Keyword [EGFR-tyrosine kinase inhibitors] Result: 1 - 20 \| Page: 1 of 2
1.	Design, Synthesis And SAR Of Novel Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors
2.	Solid-phase Synthesis And Biological Evaluation Of Quinazoline Libraries And The Application Of Samarium Reagents In Organic Synthesis
3.	Expression And Synthesis Of 5 - Pyrimidino [5,4-b] Indole Derivatives Of EGFR Tyrosine Kinase Inhibitors
4.	Investigation On The Antitumor Effects And Mechanisms Of EGFR Tyrosine Kinase Inhibitors AL68 Series
5.	Design,Synthesis And Anti-tumor Evaluation Of Quinazoline Libraries
6.	Structure-and Ligand-based Study Of Histamine 2 Receptor Agonists And The EGFR Tyrosine Kinase Inhibitors
7.	Design, Synthesis And Biological Evaluation Of EGFR Tyrosine Kinase Inhibitors And The Synthesis Of The Heterocyclic Compound Library Of Aminooxazoles
8.	Interaction Between EGFR Mutation S768I And EGFR Tyrosine Kinase Inhibitors
9.	Part Ⅰ EGFR Mutation Subtypes And Quantity With Different Efficacy Of EGFR Tyrosine Kinase Inhibitors In Non-small Cell Lung Cancer Patients Part Ⅱ Effect Of EGFR Tyrosine Kinase Inhibitors On The Survival Of EGFR Uncommon Mutation Patients With Recur
10.	Design And Synthesis Of EGFR Tyrosine Kinase Inhibitors Based Quinazoline
11.	Efficacy And Safety Of EGFR-Tyrosine Kinase Inhibitors In The Patiets With Advanced Non-Small Cell Lung Cancer Harboring Mutations Of The Epidermal Growth Factor Receptor
12.	TOPK Promotes Resistance To EGFR Tyrosine Kinase Inhibitors By Phosphorylating And Activating C-Jun In Lung Cancer
13.	Efficacy Of EGFR-Tyrosine Kinase Inhibitors And Clinical Pathologic Features Analysis Between Exon 19 Deletion And L858R Mutation With Advanced Non-Small Cell Lung Cancer
14.	JMJD2C Facilitates Self-Renewal Of Stem-Like Cells And Confers Resistance To EGFR Inhibitors In Non-Small Cell Lung Cancer
15.	Pemetrexed With Gefitinib Or Pemetrexed Alone In Advanced Lung Adenocarcinoma With Acquired Resistance To EGFR Tyrosine Kinase Inhibitors
16.	Intercalated Combination Of Chemotherapy And Tyrosine Kinase Inhibitors As First-line Treatment For Patients With Non-Small-Cell Lung Cancer
17.	Sequential Treatment Of EGFR Tyrosine Kinase Inhibitors And Platinum Doublet Chemotherapy On Survival Of Advanced Non-small-cell Lung Cancer With EGFR Mutations
18.	Characteristics And Survival In Non-small Cell Lung Cancer Patients Harbored Primary And Acquired EGFR T790M Mutation
19.	Combining Thalidomide With EGFR Tyrosine Kinase Inhibitors Synergistically Inhibits NSCLC Cells In Vitro And In Vivo
20.	The Characteristics Of Epidermal Growth Factor Receptor With Rare Mutations In Non-small Cell Lung Cancer And The Effect Of EGFR Tyrosine Kinase Inhibitors On Them
<<First <Prev Next> Last>> Jump to